Scientists pinpoint TNF blockade to curb ICI heart risks in cancer patients
Researchers at Cincinnati Children's Hospital Medical Center have identified a targeted way to prevent deadly heart inflammation from immune checkpoint inhibitors, popular cancer drugs like Keytruda and Opdivo. Blocking a specific TNF signaling pathway in mice stopped the cardiac damage without reducing the treatments' tumor-fighting power.